Published in Br Med J on September 21, 1968
Paraquat lung: a reappraisal. Thorax (1974) 1.11
The pathology of the lung in paraquat poisoning. J Clin Pathol Suppl (R Coll Pathol) (1975) 0.98
Paraquat poisoning in children. Arch Dis Child (1970) 0.97
Paraquat suicide in a young woman: results of therapy directed against the superoxide radical. Yale J Biol Med (1978) 0.93
Paraquat in the rabbit. Br J Ind Med (1971) 0.92
Pulmonary ultrastructure of the late aspects of human paraquat poisoning. Am J Pathol (1978) 0.85
Effects of the herbicide paraquat on the ultrastructure of mouse kidney. Am J Pathol (1971) 0.83
Effect of ingestion of paraquat on a 20-week gestation fetus. Postgrad Med J (1982) 0.82
Paraquat poisoning. Postgrad Med J (1969) 0.77
Fetal poisoning after maternal paraquat ingestion during third trimester of pregnancy: case report and literature review. J Med Toxicol (2007) 0.75
Paraquat toxicity. Br Med J (1970) 0.75
Death from paraquat in a child. Lancet (1968) 4.29
Acute renal failure in case of Paraquat poisoning. Br Med J (1968) 2.74
Prevention of prolonged labour. Br Med J (1969) 7.37
Structure and function of heparan sulphate proteoglycans. Biochem J (1986) 2.78
Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J Biol Chem (1992) 2.20
Control of morphology, cytoskeleton and migration by syndecan-4. J Cell Sci (1999) 2.17
Active management of labour and cephalopelvic disproportion. J Obstet Gynaecol Br Commonw (1970) 2.06
Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem (1998) 1.97
Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides. Biochem J (1985) 1.86
Mucous glycoproteins: a gel of a problem. Essays Biochem (1985) 1.82
Liver heparan sulfate structure. A novel molecular design. J Biol Chem (1994) 1.76
Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res (1990) 1.68
Examination of the substrate specificity of heparin and heparan sulfate lyases. Biochemistry (1990) 1.60
The composition of tracheal mucus and the nervous control of its secretion in the cat. Proc R Soc Lond B Biol Sci (1975) 1.58
Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report. Cancer (1988) 1.57
Public awareness of testicular cancer and the value of self examination. Br Med J (Clin Res Ed) (1986) 1.57
The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse. J Biol Chem (2001) 1.55
Effect of actinomycin D on Paget's disease of bone. Br Med J (1971) 1.54
Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J Biol Chem (1994) 1.52
Specific binding of the chemokine platelet factor 4 to heparan sulfate. J Biol Chem (1997) 1.43
The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific. J Biol Chem (1997) 1.41
Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. J Biol Chem (1994) 1.40
Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structure. Biochem J (1991) 1.36
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J Cancer (1995) 1.35
Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biol (1998) 1.35
Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2. Glycobiology (2000) 1.34
Patients' delay in the presentation of testis cancer in Ireland. Br J Urol (1987) 1.32
Separation of alkaline phosphatase enzymes in human serum using gel-filtration (Sephadex G-200) techniques. Cancer (1967) 1.31
Highly sensitive sequencing of the sulfated domains of heparan sulfate. J Biol Chem (1999) 1.27
A strategy for rapid sequencing of heparan sulfate and heparin saccharides. Proc Natl Acad Sci U S A (1999) 1.27
Proteoglycans in haemopoietic cells. Biochim Biophys Acta (1990) 1.24
Specific association of iduronic acid-rich dermatan sulphate with the extracellular matrix of human skin fibroblasts cultured on collagen gels. Biochem J (1983) 1.24
Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem (1998) 1.24
Regulation of haemopoiesis in long-term bone marrow cultures. IV. Glycosaminoglycan synthesis and the stimulation of haemopoiesis by beta-D-xylosides. J Cell Biol (1983) 1.22
Sarcoidosis and lymphoma in the same patient. Postgrad Med J (1983) 1.21
Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. J Biol Chem (1994) 1.21
Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res (1994) 1.16
Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem (1998) 1.14
Molecular cloning of the major cell surface heparan sulfate proteoglycan from rat liver. J Biol Chem (1992) 1.13
Recovery from severe paraquat poisoning following forced diuresis and immunosuppressive therapy. J Ir Med Assoc (1971) 1.12
Tissue-type plasminogen activator, a new prognostic marker in breast cancer. Cancer Res (1988) 1.12
Substance abuse and HIV: considerations with regard to methamphetamines and other recreational drugs for nursing practice and research. J Assoc Nurses AIDS Care (2000) 1.12
Heparan sulphate. Int J Biochem Cell Biol (1997) 1.12
Three-dimensional structure of a purple lipoxygenase. J Am Chem Soc (2001) 1.11
Identification of two binding sites for wheat-germ agglutinin on polylactosamine-type oligosaccharides. Biochem J (1985) 1.11
Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma. Int J Cancer (1999) 1.10
Interaction of heparan sulfate from mammary cells with acidic fibroblast growth factor (FGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate. J Biol Chem (1998) 1.10
Carbohydrate-binding properties of lectins: a possible approach to lectin nomenclature and classification. Review. Biosci Rep (1984) 1.08
Separation of radiolabelled glycosaminoglycan oligosaccharides by polyacrylamide-gel electrophoresis. Biochem J (1984) 1.05
Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior. J Biol Chem (1994) 1.04
Oligosaccharide mapping of heparan sulphate by polyacrylamide-gradient-gel electrophoresis and electrotransfer to nylon membrane. Biochem J (1988) 1.03
Identification of an extended N-acetylated sequence adjacent to the protein-linkage region of fibroblast heparan sulphate. Biochem J (1987) 1.03
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer. Br J Cancer (1995) 1.03
Molecular organization of heparan sulphate from human skin fibroblasts. Biochem J (1990) 1.03
Mucus-glycoproteins (mucins) of the cat trachea: characterisation and control of secretion. Biochim Biophys Acta (1986) 1.02
Elucidation of the structural features of heparan sulfate important for interaction with the Hep-2 domain of fibronectin. J Biol Chem (2000) 1.01
Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells. Br J Cancer (1997) 1.00
Alzheimer's beta-amyloid peptide 1-42 induces a phagocytic response in murine microglia. J Neurochem (1998) 0.98
Heparan sulphate synthetic and editing enzymes in ovarian cancer. Br J Cancer (2007) 0.97
Cell adhesion in the stromal regulation of haemopoiesis. Baillieres Clin Haematol (1992) 0.97
Sequence analysis of heparan sulphate and heparin oligosaccharides. Biochem J (1999) 0.97
Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate. J Biol Chem (1998) 0.97
The effect of alpha4 beta1-integrin binding sequences of fibronectin on growth of cells from human hematopoietic progenitors. Blood (1998) 0.96
Role of the cellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures. J Cell Sci (1983) 0.96
Isolation and characterization of the integral glycosaminoglycan constituents of human amyloid A and monoclonal light-chain amyloid fibrils. Biochem J (1991) 0.95
Heterogeneity of cell-associated and secretory heparan sulphate proteoglycans produced by cultured human neuroblastoma cells. Biochim Biophys Acta (1984) 0.95
Structure and metabolism of glycoproteins and glycosaminoglycans secreted by organ cultures of rabbit trachea. Biochem J (1975) 0.95
Proteoglycans in cellular differentiation and neoplasia. Biochem Soc Trans (1984) 0.95
Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer. Cancer (1994) 0.94
Structural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII). Biochem J (1996) 0.93
The lipoxygenases in developing soybean seeds, their characterization and synthesis in vitro. Plant Physiol (1986) 0.92
Homocystinuria. II. Subnormal serum folate levels, increased folate clearance and effects of folic acid therapy. Am J Med (1968) 0.92
Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver. Biochem J (1991) 0.92
IL-1 beta converting enzyme (ICE) is not required for apoptosis induced by lymphokine deprivation in an IL-2-dependent T cell line. J Immunol (1995) 0.91
Receptors for fibroblast growth factors. Immunol Cell Biol (1995) 0.91
Hepatocyte growth factor/scatter factor and its interaction with heparan sulphate and dermatan sulphate. Biochem Soc Trans (2003) 0.91
Serum sialic acid and CEA concentrations in human breast cancer. Br J Cancer (1980) 0.90
The initial characterization of the iron environment in lipoxygenase by Mössbauer spectroscopy. Eur J Biochem (1990) 0.90
Production of heparan sulphate proteoglycans by human bone marrow stromal cells. J Cell Sci (1991) 0.90
A general method for the detection and mapping of submicrogram quantities of glycosaminoglycan oligosaccharides on polyacrylamide gels by sequential staining with azure A and ammoniacal silver. Anal Biochem (1990) 0.89
Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings. Clin Chem (1991) 0.89
Mucins in cat airway secretions. Biochem J (1991) 0.89
Urokinase plasminogen activator and prognosis in breast cancer. Lancet (1990) 0.89
Chondroitin sulphate proteoglycan production by NK cells and T cells: effects of xylosides on proliferation and cytotoxic function. Immunology (1988) 0.89
Complications of laparoscopic surgery for rectal cancer: avoidance and management. Semin Surg Oncol (2000) 0.88
The nature and origin of tracheal secretions released in response to pilocarpine and ammonia [proceedings]. J Physiol (1978) 0.88
Sequence analysis of heparan sulphate indicates defined location of N-sulphated glucosamine and iduronate 2-sulphate residues proximal to the protein-linkage region. Biochem J (1991) 0.88
Expression of proteoglycan core proteins in human bone marrow stroma. Biochem J (1999) 0.88
Synthesis of glycosaminoglycans by human skin fibroblasts cultured on collagen gels. Biochem J (1980) 0.88
Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation. J Biol Chem (1999) 0.87
Structural comparison of fibroblast growth factor-specific heparan sulfates derived from a growing or differentiating neuroepithelial cell line. Glycobiology (1998) 0.86
Cholinergic therapies for Alzheimer's disease. Palliative or disease altering? Arzneimittelforschung (1995) 0.86
Differences in the distribution of O-sulphate groups of cell-surface and secreted heparan sulphate produced by human neuroblastoma cells in culture. Biochim Biophys Acta (1983) 0.86
Urokinase plasminogen activator as a predictor of aggressive disease in breast cancer. Enzyme Protein (1996) 0.85
Metabolic properties of a homogeneous proteoglycan of a haemopoietic stem cell line, FDCP-mix. Biochem J (1989) 0.85
Soft tissue and visceral sarcomas in Irish patients. Interim analysis of data obtained by the Dublin Soft Tissue Tumour Panel. Ir J Med Sci (1994) 0.85
Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survival. Clin Chem (1992) 0.85
The importance of varying molecular size, differential heat and urea inactivation of phosphatase in the identification of disease patterns. Ann N Y Acad Sci (1969) 0.84
Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis. Cancer Chemother Pharmacol (1986) 0.84
An evaluation of predisposing factors for testis cancer in Ireland. Eur Urol (1988) 0.84
Synthesis of glycosaminoglycans by cloned bovine endothelial cells cultured on collagen gels. Eur J Biochem (1983) 0.84
Hypothalamic-pituitary-adrenal function in patients receiving intermittent high dose prednisone therapy for lymphoma. Ir Med J (1984) 0.83